Measuring the quality and safety of upper endoscopy in patients taking glucagon-like peptide 1 receptor agonists

Similar Items

• Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
  by: Seungah Lee, et al.
  Published: (2017-03-01)
• Nephroprotective potential of glucagon-like peptide-1 receptor agonists
  by: Minara S. Shamkhalova, et al.
  Published: (2020-04-01)
• Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
  by: Yu Mi Kang, et al.
  Published: (2016-06-01)
• How glucagon-like peptide 1 receptor agonists work
  by: Christine Rode Andreasen, et al.
  Published: (2021-07-01)
• Glucagon-like peptide-1 receptor agonists in patients treated with antipsychotics
  by: A. Delgado, et al.
  Published: (2021-04-01)